Reporte zur Charge AN6198

Symptomtext

"My" menstrual cycle has increased since the vaccine. Prior to getting the vaccine, "my" cycle was average around 28 days now it has increasedto 32 days.; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: AN6198) via an unspecified route of administration in the left arm on 02Mar2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 08Mar2021, since the vaccine, the patient's menstrual cycle had increased. Prior to getting the vaccine, her cycle was average around 28 days and it had increased to 32 days. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual cycle had increased was not resolved at the time of this report. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm left on 23Mar2021 at 09:30(at the age of 30-years-old)as a single dose for COVID-19 immunisation. No follow-up attempts are possible. No further information is expected.